台股 » 個股 » 訊聯 » 籌碼相關 » 融資融券與借券

訊聯

(1784)
可現股當沖
  • 股價
    66.7
  • 漲跌
    ▲0.8
  • 漲幅
    +1.21%
  • 成交量
    722
  • 產業
    上櫃 生技醫療類股
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
訊聯 (1784) 融資融券與借券

股票投資新手教室: 一分鐘搞懂「融資融券」

訊聯 (1784) 融資融券與借券

訊聯 (1784) 近三十日融資融券與借券賣出
日期 融資 融券 資券互抵(張) 資券當沖(%) 券資比(%) 價格 比例 成交量
增加 餘額 使用率% 增加 餘額 使用率%
05/06403,48528.093240.1910.140.6966.71.21%722
05/03-253,44527.77-1210.17000.6165.9-0.90%434
05/02643,47027.9714220.1820.160.6366.53.58%1,237
04/30-83,40627.45-180.06000.2364.2-1.38%239
04/29203,41427.52-790.07000.2665.1-1.96%618
04/26-2313,39427.36-1160.1330.10.4766.4-4.32%2,957
04/255153,62529.229170.14000.4769.49.98%1,200
04/24-333,11025.07-1180.06000.2663.1-1.56%401
04/2373,14325.3315190.1510.090.664.15.43%1,132
04/22303,13625.28440.03000.1360.83.40%573
04/19-483,10625.0400020.39058.8-4.08%517
04/18163,15425.4200000061.3-0.81%115
04/17-153,13825.2900000061.80.65%121
04/16-63,15325.4200000061.4-3.46%336
04/1543,15925.4600000063.6-0.63%227
04/1273,15525.4300000064-0.78%143
04/11183,14825.3700000064.5-2.57%258
04/1023,12725.21-30000066.20.46%218
04/09-73,12825.21030.02000.165.9-0.90%275
04/08-203,13525.27230.02000.166.53.10%633
04/03-213,15525.43-1010.01000.0364.5-1.23%355
04/02163,17625.60110.09000.3565.33.65%322
04/01-33,16025.470110.09000.35630.96%102
03/29-83,16325.50110.09000.3562.4-1.27%126
03/28-173,17125.560110.09000.3563.21.12%169
03/27-163,18825.7-2110.09000.3562.50.64%130
03/26-33,20425.83-9130.1000.4162.1-2.05%266
03/25-633,20725.850220.18000.6963.4-1.25%253
03/22-23,27026.360220.18000.6764.2-0.31%295
03/21413,27226.37-3220.18000.6764.4-2.42%533
日期 融券 借券賣出 價格 比例 成交量
買進 賣出 增加 餘額 使用率% 賣出 還券 調整 增加 餘額
05/06030324@Limit20.19431602780566.71.21%722
05/03210-121@Limit20.1723002377865.9-0.90%434
05/0201401422@Limit20.1844004475566.53.58%1,237
04/30100-18@Limit20.0624901571164.2-1.38%239
04/29700-79@Limit20.0764805669665.1-1.96%618
04/26210-116@Limit20.131080010864066.4-4.32%2,957
04/25090917@Limit20.14870153269.49.98%1,200
04/241100-118@Limit20.06000053163.1-1.56%401
04/2311601519@Limit20.1519001953164.15.43%1,132
04/2204044@Limit20.0316301351260.83.40%573
04/1900000@Limit20000049958.8-4.08%517
04/1800000@Limit20000049961.3-0.81%115
04/1700000@Limit20000049961.80.65%121
04/1600000@Limit20000049961.4-3.46%336
04/1500000@Limit20300349963.6-0.63%227
04/1200000@Limit20000049664-0.78%143
04/1100000@Limit20000049664.5-2.57%258
04/10003-30@Limit20000049666.20.46%218
04/0900003@Limit20.02000049665.9-0.90%275
04/0813023@Limit20.02000049666.53.10%633
04/031000-101@Limit20.01540149664.5-1.23%355
04/02000011@Limit20.09110049565.33.65%322
04/01000011@Limit20.091100-9495630.96%102
03/29000011@Limit20.09370-450462.4-1.27%126
03/28000011@Limit20.0910001050863.21.12%169
03/27200-211@Limit20.09000049862.50.64%130
03/26900-913@Limit20.1000049862.1-2.05%266
03/25000022@Limit20.18010-149863.4-1.25%253
03/22000022@Limit20.18900949964.2-0.31%295
03/21300-322@Limit20.18100149064.4-2.42%533
日期 當沖成交張數 買進成交金額 賣出成交金額 現股當沖率(%) 平均盈虧
05/0625917,308,90017,402,60035.87361.78
05/031499,918,7009,910,00034.33-58.39
05/0248932,805,90032,924,20039.53241.92
04/30382,455,1002,456,70015.942.11
04/291338,743,8008,768,60021.52186.47
04/261,29588,913,60088,936,50043.7917.68
04/2527418,220,10018,439,00022.83798.91
04/24664,193,3004,198,90016.4684.85
04/2347229,930,80030,233,50041.7641.31
04/2217510,709,60010,722,80030.5475.43
04/19704,164,0004,133,00013.54-442.86
04/185307,100307,0004.35-20
04/1712743,800743,5009.92-25
04/1611679,200677,2003.27-181.82
04/15221,391,7001,391,4009.69-13.64
04/1210642,600645,0006.99240
04/11261,701,1001,706,40010.08203.85
04/10382,520,4002,522,60017.4357.89
04/09543,577,9003,574,80019.64-57.41
04/0820413,539,00013,537,00032.23-9.8
04/03382,440,4002,453,00010.7331.58
04/02422,676,5002,709,10013.04776.19
04/01221,378,6001,381,60021.57136.36
03/29171,078,7001,070,00013.49-511.76
03/28593,749,7003,739,60034.91-171.19
03/2710625,200627,1007.69190
03/2612748,600753,8004.51433.33
03/25352,241,9002,240,40013.83-42.86
03/22533,412,8003,412,10017.97-13.21
03/211016,581,2006,555,20018.95-257.43
訊聯細胞智藥攜手韓新創公司 搶攻外泌體商機Anue鉅亨-2023/11/27
〈訊聯展望〉看好基因定序健保商機 脊髓肌肉萎縮檢測滲透率上看90%Anue鉅亨-2023/08/09
訊聯 相關文章
訊聯 相關影音